Latest On Crinetics Pharmaceuticals, Inc (CRNX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-25 19:43 EST | News | Crinetics Pharmaceuticals And Its Value Proposition In Acromegaly | N/A |  |
| 2023-05-04 23:54 EST | News | Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43M | N/A | |
| 2023-03-06 12:48 EST | News | Evaluating Crinetics' Oral Long Shot For Acromegaly | N/A | |
| 2023-02-28 18:44 EST | News | Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41M | N/A | |
| 2022-12-30 22:15 EST | News | Crinetics: FY23 Could Be Turning Point With Two Phase 3 Acromegaly Readouts | N/A | |
| 2022-11-29 04:07 EST | News | Crinetics says FDA didn’t clear Phase 2 study request for hyperinsulinism drug | N/A | |
| 2022-11-15 00:39 EST | News | Crinetics Pharmaceuticals GAAP EPS of -$0.78 beats by $0.03, revenue of $0.46M beats by $0.26M | N/A | |
| 2022-08-12 17:31 EST | News | Crinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28M | N/A | |
| 2022-06-13 22:31 EST | News | Crinetics: Late-Stage Acromegaly Disease Studies Will Be Major Inflection Point | N/A | |
| 2022-05-25 15:30 EST | News | Crinetics hormone CRN04894 therapy shows promise in early-stage study | N/A | |
| 2022-05-13 09:56 EST | News | Crinetics Pharmaceuticals GAAP EPS of -$0.73 misses by $0.17, revenue of $3.13M misses by $2.07M | N/A | |
| 2022-04-29 23:10 EST | News | Crinetics: An Orphan Disease Innovator On The Rise | N/A | |
| 2022-04-24 11:40 EST | News | Crinetics Pharmaceuticals: Endocrinology Focus To Pay Off As Multi-Faceted Pipeline Makes Progress | N/A | |
| 2022-04-13 16:17 EST | News | Crinetics Pharmaceuticals prices $125M stock offering | N/A | |
| 2022-04-01 04:52 EST | News | Crinetics stock gains on hyperinsulinism candidate's trial data; JMP raises PT | N/A | |
| 2022-03-31 09:08 EST | News | Crinetics Pharmaceuticals reports results | N/A | |
| 2022-03-30 16:39 EST | News | Crinetics shows dose-dependent effect of hyperinsulinism candidate in early trial | N/A | |
| 2022-03-18 16:25 EST | News | Crinetics delays early Phase 1 data for experimental therapy due to COVID-19 | N/A | |
| 2022-02-28 09:07 EST | News | Crinetics, Sanwa ink licensing deal for cancer/hormonal disorder drug in Japan | N/A | |
| 2021-10-22 05:14 EST | News | Crinetics Pharmaceuticals prices $150M in stock offering | N/A | |
| 2021-10-21 03:29 EST | News | Crinetics drops after announcing common stock offering | N/A | |
| 2021-09-21 15:29 EST | News | Crinetics posts preliminary results from early-stage CRN04777 hyperinsulinism study | N/A | |
| 2021-09-21 15:23 EST | News | Crinetics Pharmaceuticals (CRNX) Investor Presentation - Slideshow | N/A | |
| 2021-09-02 17:30 EST | News | Crinetics Pharmaceuticals names Jeff Knight as chief operating officer | N/A | |
| 2021-08-10 23:06 EST | News | Crinetics Pharmaceuticals posts positive data from early-stage CRN04894 trial | N/A | |
| 2021-08-10 23:05 EST | News | Crinetics Pharmaceuticals EPS misses by $0.10 | N/A | |
| 2021-07-29 16:43 EST | News | Crinetics Pharmaceuticals proposes $15M in private placement with Frazier Healthcare | N/A | |
| 2021-07-21 02:52 EST | News | Crinetics doses first patient in late-stage oral paltusotine acromegaly trial | N/A | |
| 2021-05-07 06:27 EST | News | Crinetics Pharmaceuticals EPS misses by $0.04 | N/A | |
| 2021-04-08 07:33 EST | News | Crinetics Pharma raises $75M via equity offering | N/A | |
| 2021-03-30 23:41 EST | News | Crinetics Pharmaceuticals, Inc. (CRNX) CEO Scott Struthers on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-30 23:41 EST | News | Crinetics Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-01-23 04:21 EST | News | Crinetics Pharmaceuticals (CRNX) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow | N/A | |
| 2020-12-13 03:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-24 07:37 EST | Analyst Rating | The Analyst Target Price has increased from $32.8 to $33.6. | Buy | |
| 2020-11-09 11:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 11:40 EST | Earnings Estimate | An EPS average of -$0.59 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-07 15:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 06:16 EST | News | Crinetics Pharmaceuticals EPS misses by $0.03 | N/A | |
| 2020-10-30 12:37 EST | Analyst Rating | The Analyst Target Price has decreased from $36.75 to $32.8. | Neutral | |
| 2020-10-26 14:41 EST | News | Crinetics Pharma lead drug successful in mid-stage acromegaly study | N/A | |
| 2020-09-26 12:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 04:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-08 04:25 EST | Analyst Rating | The Analyst Target Price has decreased from $36.8 to $36.75. | Neutral | |
| 2020-09-05 01:11 EST | News | Crinetics Pharma to advance ACTH antagonist candidate into the clinic | N/A | |
| 2020-09-05 00:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-02 11:29 EST | News | Crinetics Pharmaceuticals- Superior Molecules In Endocrinology | N/A | |
| 2020-08-09 08:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 16:03 EST | News | Crinetics Pharmaceuticals EPS beats by $0.02 | N/A | |
| 2020-07-31 00:39 EST | Financials | Company financials have been released. | Neutral | |
About Crinetics Pharmaceuticals, Inc (CRNX):
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, which is in Phase I clinical trials used for the treatment of acromegaly and neuroendocrine tumors. The company is also developing CRN01941, an oral selective nonpeptide sst2 biased agonist designed for the treatment of neuroendocrine tumors; an oral selective nonpeptide somatostatin type 5 receptor agonist for treating congenital hyperinsulinism; and an oral adrenocorticotrophic hormone antagonist for the treatment of cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.
General
- Name Crinetics Pharmaceuticals, Inc
- Symbol CRNX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 68
- Fiscal Year EndDecember
- IPO Date2018-07-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.crinetics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 1102.47
- Price/Book (Most Recent Quarter) 2.99
- Enterprise Value Revenue 961.96
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.55
- Operating Margin -17443%
- Return on Assets -25%
- Return on Equity -42%
- Revenue 392000
- Earnings Per Share -$1.62
- Revenue Per Share $0.01
- Gross Profit -40313000
- Quarterly Earnings Growth -80.7%
View More
Highlights
- Market Capitalization 531.37 million
- EBITDA -40113000
- PE Ratio -16.43
- Analyst Target Price $33.6
- Book Value Per Share $5.69
View More
Share Statistics
- Shares Outstanding 32.92 million
- Shares Float 20.69 million
- % Held by Insiders 450%
- % Held by Institutions 95.14%
- Shares Short 1.53 million
- Shares Short Prior Month 1.38 million
- Short Ratio 13.29
- Short % of Float 6%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 1.23
- 52 Week High $23.7
- 52 Week Low $11.61
- 50 Day Moving Average 15.77
- 200 Day Moving Average 14.69
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Crinetics Pharmaceuticals, Inc (CRNX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Crinetics Pharmaceuticals, Inc (CRNX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-06 | $N/A | -$0.56 | -$0.53 | -6.38% |
| 2020-06-30 | 2020-08-07 | $N/A | -$0.53 | -$0.55 | 4.21% |
| 2020-03-31 | 2020-05-08 | $N/A | -$0.71 | -$0.63 | -12.66% |
| 2019-12-31 | 2020-03-09 | $321000 | -$0.60 | -$0.68 | 11.35% |
| 2019-09-30 | 2019-11-12 | $505000 | -$0.60 | -$0.54 | -11.92% |
| 2019-06-30 | 2019-08-13 | $N/A | -$0.51 | -$0.46 | -11.79% |
| 2019-03-31 | 2019-05-13 | $367000 | -$0.37 | -$0.39 | 4.61% |
| 2018-12-31 | 2019-03-13 | $781000 | -$0.35 | -$0.41 | 15.09% |
| 2018-09-30 | 2018-11-13 | $548000 | -$0.38 | -$0.34 | -10.47% |
| 2018-06-30 | 2018-08-30 | $657000 | -$0.33 | -$0.31 | -7.32% |
Crinetics Pharmaceuticals, Inc (CRNX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Crinetics Pharmaceuticals, Inc (CRNX) Chart:
Crinetics Pharmaceuticals, Inc (CRNX) News:
Below you will find a list of latest news for Crinetics Pharmaceuticals, Inc (CRNX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Crinetics Pharmaceuticals, Inc (CRNX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 25 | 0 | CALL | 0 | 0 | 91.98 | TRUE | 0 | 0 |
| 2024-12-20 | 30 | 23.3 | CALL | 0 | 1 | 71.73 | TRUE | 0 | 0 |
| 2024-12-20 | 35 | 0 | CALL | 0 | 0 | 62.13 | TRUE | 0 | 0 |
| 2024-12-20 | 36 | 0 | CALL | 0 | 0 | 58.28 | TRUE | 0 | 0 |
| 2024-12-20 | 37 | 0 | CALL | 0 | 0 | 60.32 | TRUE | 0 | 0 |
| 2024-12-20 | 38 | 0 | CALL | 0 | 0 | 57.75 | TRUE | 0 | 0 |
| 2024-12-20 | 39 | 0 | CALL | 0 | 0 | 53.95 | TRUE | 0 | 0 |
| 2024-12-20 | 40 | 11.1 | CALL | 0 | 16 | 60.57 | TRUE | 0 | 0 |
| 2024-12-20 | 41 | 0 | CALL | 0 | 0 | 57.44 | TRUE | 0 | 0 |
| 2024-12-20 | 42 | 0 | CALL | 0 | 0 | 54.29 | TRUE | 0 | 0 |
| 2024-12-20 | 43 | 0 | CALL | 0 | 0 | 52.72 | TRUE | 0 | 0 |
| 2024-12-20 | 44 | 0 | CALL | 0 | 0 | 53.16 | TRUE | 0 | 0 |
| 2024-12-20 | 45 | 8.5 | CALL | 0 | 10 | 51.76 | TRUE | 0 | 0 |
| 2024-12-20 | 46 | 0 | CALL | 0 | 0 | 52.05 | TRUE | 0 | 0 |
| 2024-12-20 | 47 | 10.4 | CALL | 0 | 5 | 51.31 | TRUE | 0 | 0 |
| 2024-12-20 | 48 | 4.5 | CALL | 0 | 1 | 50.26 | TRUE | 0 | 0 |
| 2024-12-20 | 49 | 0 | CALL | 0 | 0 | 49.47 | TRUE | 0 | 0 |
| 2024-12-20 | 50 | 5 | CALL | 0 | 12 | 49.45 | TRUE | 0 | 0 |
| 2024-12-20 | 55 | 3 | CALL | 0 | 13 | 46.83 | FALSE | 0 | 0 |
| 2024-12-20 | 60 | 2.8 | CALL | 0 | 21 | 54.96 | FALSE | 0 | 0 |
| 2024-12-20 | 65 | 0.44 | CALL | 0 | 13 | 65.8 | FALSE | 0 | 0 |
| 2024-12-20 | 70 | 1.35 | CALL | 0 | 21 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 75 | 0.9 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 80 | 1.15 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 25 | 0.75 | PUT | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 30 | 0.95 | PUT | 0 | 11 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 35 | 1 | PUT | 0 | 7 | 107.39 | FALSE | 0 | 0 |
| 2024-12-20 | 36 | 0.85 | PUT | 0 | 7 | 102.28 | FALSE | 0 | 0 |
| 2024-12-20 | 37 | 0.95 | PUT | 0 | 5 | 98.96 | FALSE | 0 | 0 |
| 2024-12-20 | 38 | 1.35 | PUT | 0 | 13 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 39 | 1.15 | PUT | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 40 | 1.1 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 41 | 1.3 | PUT | 10 | 2 | 59.19 | FALSE | 1.3 | 0 |
| 2024-12-20 | 42 | 1.8 | PUT | 0 | 1 | 60.17 | FALSE | 0 | 0 |
| 2024-12-20 | 43 | 1.95 | PUT | 0 | 1 | 70.53 | FALSE | 0 | 0 |
| 2024-12-20 | 44 | 0 | PUT | 0 | 0 | 66.67 | FALSE | 0 | 0 |
| 2024-12-20 | 45 | 4 | PUT | 0 | 10 | 63.44 | FALSE | 0 | 0 |
| 2024-12-20 | 46 | 2.56 | PUT | 0 | 1 | 59.51 | FALSE | 0 | 0 |
| 2024-12-20 | 47 | 0 | PUT | 0 | 0 | 54.64 | FALSE | 0 | 0 |
| 2024-12-20 | 48 | 9.9 | PUT | 0 | 0 | 53.82 | FALSE | 0 | 0 |
| 2024-12-20 | 49 | 0 | PUT | 0 | 0 | 54.65 | FALSE | 0 | 0 |
| 2024-12-20 | 50 | 4.6 | PUT | 0 | 6 | 54.55 | FALSE | 0 | 0 |
| 2024-12-20 | 55 | 0 | PUT | 0 | 0 | 53.99 | TRUE | 0 | 0 |
| 2024-12-20 | 60 | 0 | PUT | 0 | 0 | 50.07 | TRUE | 0 | 0 |
| 2024-12-20 | 65 | 0 | PUT | 0 | 0 | 51.46 | TRUE | 0 | 0 |
| 2024-12-20 | 70 | 0 | PUT | 0 | 0 | 52.74 | TRUE | 0 | 0 |
| 2024-12-20 | 75 | 0 | PUT | 0 | 0 | 54.63 | TRUE | 0 | 0 |
| 2024-12-20 | 80 | 0 | PUT | 0 | 0 | 68.84 | TRUE | 0 | 0 |
| 2025-01-17 | 25 | 29.88 | CALL | 0 | 0 | 74.55 | TRUE | 0 | 0 |
| 2025-01-17 | 30 | 25.14 | CALL | 0 | 0 | 57.08 | TRUE | 0 | 0 |
| 2025-01-17 | 35 | 0 | CALL | 0 | 0 | 58.95 | TRUE | 0 | 0 |
| 2025-01-17 | 40 | 0 | CALL | 0 | 0 | 51.34 | TRUE | 0 | 0 |
| 2025-01-17 | 45 | 10.25 | CALL | 0 | 3 | 50.98 | TRUE | 0 | 0 |
| 2025-01-17 | 50 | 7.1 | CALL | 0 | 17 | 51.16 | TRUE | 0 | 0 |
| 2025-01-17 | 55 | 3.84 | CALL | 3 | 570 | 42.77 | FALSE | -0.16 | -0.04 |
| 2025-01-17 | 60 | 2 | CALL | 0 | 22 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 65 | 1.45 | CALL | 0 | 6 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 70 | 0.85 | CALL | 0 | 32 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 75 | 1.3 | CALL | 0 | 13 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 80 | 1 | CALL | 0 | 59 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 25 | 0.55 | PUT | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 30 | 0.6 | PUT | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 35 | 1.85 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 40 | 1.65 | PUT | 0 | 20 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 45 | 0 | PUT | 0 | 0 | 55.63 | FALSE | 0 | 0 |
| 2025-01-17 | 50 | 4 | PUT | 0 | 15 | 52.42 | FALSE | 0 | 0 |
| 2025-01-17 | 55 | 0 | PUT | 0 | 0 | 45.42 | TRUE | 0 | 0 |
| 2025-01-17 | 60 | 0 | PUT | 0 | 0 | 43.03 | TRUE | 0 | 0 |
| 2025-01-17 | 65 | 0 | PUT | 0 | 0 | 43.57 | TRUE | 0 | 0 |
| 2025-01-17 | 70 | 0 | PUT | 0 | 0 | 47.77 | TRUE | 0 | 0 |
| 2025-01-17 | 75 | 0 | PUT | 0 | 0 | 54.38 | TRUE | 0 | 0 |
| 2025-01-17 | 80 | 0 | PUT | 0 | 0 | 61.13 | TRUE | 0 | 0 |
| 2025-03-21 | 30 | 0 | CALL | 0 | 0 | 54.04 | TRUE | 0 | 0 |
| 2025-03-21 | 35 | 20.45 | CALL | 0 | 3 | 55.11 | TRUE | 0 | 0 |
| 2025-03-21 | 40 | 0 | CALL | 0 | 0 | 52.37 | TRUE | 0 | 0 |
| 2025-03-21 | 45 | 0 | CALL | 0 | 0 | 50.44 | TRUE | 0 | 0 |
| 2025-03-21 | 50 | 0 | CALL | 0 | 0 | 48.47 | TRUE | 0 | 0 |
| 2025-03-21 | 55 | 7.9 | CALL | 0 | 4 | 55.47 | FALSE | 0 | 0 |
| 2025-03-21 | 60 | 3.3 | CALL | 0 | 1 | 51.45 | FALSE | 0 | 0 |
| 2025-03-21 | 65 | 2.7 | CALL | 0 | 8 | 45.84 | FALSE | 0 | 0 |
| 2025-03-21 | 70 | 0 | CALL | 0 | 0 | 52.4 | FALSE | 0 | 0 |
| 2025-03-21 | 75 | 2.1 | CALL | 0 | 11 | 55.64 | FALSE | 0 | 0 |
| 2025-03-21 | 80 | 1.5 | CALL | 0 | 1 | 63.25 | FALSE | 0 | 0 |
| 2025-03-21 | 30 | 0.38 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 35 | 1.4 | PUT | 0 | 10 | 74.69 | FALSE | 0 | 0 |
| 2025-03-21 | 40 | 0 | PUT | 0 | 0 | 60.32 | FALSE | 0 | 0 |
| 2025-03-21 | 45 | 0 | PUT | 0 | 0 | 52.17 | FALSE | 0 | 0 |
| 2025-03-21 | 50 | 0 | PUT | 0 | 0 | 55.34 | FALSE | 0 | 0 |
| 2025-03-21 | 55 | 0 | PUT | 0 | 0 | 53.17 | TRUE | 0 | 0 |
| 2025-03-21 | 60 | 0 | PUT | 0 | 0 | 47.48 | TRUE | 0 | 0 |
| 2025-03-21 | 65 | 0 | PUT | 0 | 0 | 46.53 | TRUE | 0 | 0 |
| 2025-03-21 | 70 | 0 | PUT | 0 | 0 | 45.93 | TRUE | 0 | 0 |
| 2025-03-21 | 75 | 0 | PUT | 0 | 0 | 42.07 | TRUE | 0 | 0 |
| 2025-03-21 | 80 | 0 | PUT | 0 | 0 | 50.4 | TRUE | 0 | 0 |
| 2025-12-19 | 25 | 25.75 | CALL | 0 | 10 | 61.33 | TRUE | 0 | 0 |
| 2025-12-19 | 30 | 0 | CALL | 0 | 0 | 57.3 | TRUE | 0 | 0 |
| 2025-12-19 | 35 | 0 | CALL | 0 | 0 | 55.81 | TRUE | 0 | 0 |
| 2025-12-19 | 40 | 0 | CALL | 0 | 0 | 52.42 | TRUE | 0 | 0 |
| 2025-12-19 | 45 | 0 | CALL | 0 | 0 | 50.56 | TRUE | 0 | 0 |
| 2025-12-19 | 50 | 14.18 | CALL | 0 | 50 | 49.7 | TRUE | 0 | 0 |
| 2025-12-19 | 55 | 9 | CALL | 0 | 2 | 48.54 | FALSE | 0 | 0 |
| 2025-12-19 | 60 | 11 | CALL | 0 | 6 | 48.31 | FALSE | 0 | 0 |
| 2025-12-19 | 65 | 0 | CALL | 0 | 0 | 45.81 | FALSE | 0 | 0 |
| 2025-12-19 | 70 | 5.1 | CALL | 0 | 0 | 46.66 | FALSE | 0 | 0 |
| 2025-12-19 | 75 | 8 | CALL | 0 | 1 | 44.26 | FALSE | 0 | 0 |
| 2025-12-19 | 80 | 0 | CALL | 0 | 0 | 45.75 | FALSE | 0 | 0 |
| 2025-12-19 | 25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-12-19 | 30 | 0 | PUT | 0 | 0 | 60.31 | FALSE | 0 | 0 |
| 2025-12-19 | 35 | 0 | PUT | 0 | 0 | 52.3 | FALSE | 0 | 0 |
| 2025-12-19 | 40 | 0 | PUT | 0 | 0 | 50.42 | FALSE | 0 | 0 |
| 2025-12-19 | 45 | 0 | PUT | 0 | 0 | 49.78 | FALSE | 0 | 0 |
| 2025-12-19 | 50 | 12.75 | PUT | 0 | 10 | 47.36 | FALSE | 0 | 0 |
| 2025-12-19 | 55 | 0 | PUT | 0 | 0 | 48.05 | TRUE | 0 | 0 |
| 2025-12-19 | 60 | 0 | PUT | 0 | 0 | 47.19 | TRUE | 0 | 0 |
| 2025-12-19 | 65 | 0 | PUT | 0 | 0 | 46.1 | TRUE | 0 | 0 |
| 2025-12-19 | 70 | 26.9 | PUT | 0 | 1 | 44.78 | TRUE | 0 | 0 |
| 2025-12-19 | 75 | 0 | PUT | 0 | 0 | 44.61 | TRUE | 0 | 0 |
| 2025-12-19 | 80 | 0 | PUT | 0 | 0 | 43.05 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 30.2 | CALL | 0 | 1 | 58.75 | TRUE | 0 | 0 |
| 2026-01-16 | 30 | 0 | CALL | 0 | 0 | 54.97 | TRUE | 0 | 0 |
| 2026-01-16 | 35 | 0 | CALL | 0 | 0 | 55.45 | TRUE | 0 | 0 |
| 2026-01-16 | 40 | 19.36 | CALL | 0 | 10 | 53.41 | TRUE | 0 | 0 |
| 2026-01-16 | 45 | 0 | CALL | 0 | 0 | 51.27 | TRUE | 0 | 0 |
| 2026-01-16 | 50 | 12.5 | CALL | 0 | 2 | 50.24 | TRUE | 0 | 0 |
| 2026-01-16 | 55 | 14.2 | CALL | 0 | 1 | 50.11 | FALSE | 0 | 0 |
| 2026-01-16 | 60 | 0 | CALL | 0 | 0 | 48.75 | FALSE | 0 | 0 |
| 2026-01-16 | 65 | 0 | CALL | 0 | 0 | 48.47 | FALSE | 0 | 0 |
| 2026-01-16 | 70 | 4 | CALL | 0 | 5 | 47.23 | FALSE | 0 | 0 |
| 2026-01-16 | 75 | 0 | CALL | 0 | 0 | 45.04 | FALSE | 0 | 0 |
| 2026-01-16 | 80 | 2.63 | CALL | 0 | 5 | 45.4 | FALSE | 0 | 0 |
| 2026-01-16 | 25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 30 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 35 | 0 | PUT | 0 | 0 | 54.17 | FALSE | 0 | 0 |
| 2026-01-16 | 40 | 0 | PUT | 0 | 0 | 52.08 | FALSE | 0 | 0 |
| 2026-01-16 | 45 | 0 | PUT | 0 | 0 | 51.08 | FALSE | 0 | 0 |
| 2026-01-16 | 50 | 0 | PUT | 0 | 0 | 48.52 | FALSE | 0 | 0 |
| 2026-01-16 | 55 | 0 | PUT | 0 | 0 | 46.92 | TRUE | 0 | 0 |
| 2026-01-16 | 60 | 0 | PUT | 0 | 0 | 46.12 | TRUE | 0 | 0 |
| 2026-01-16 | 65 | 0 | PUT | 0 | 0 | 46.42 | TRUE | 0 | 0 |
| 2026-01-16 | 70 | 0 | PUT | 0 | 0 | 45.48 | TRUE | 0 | 0 |
| 2026-01-16 | 75 | 0 | PUT | 0 | 0 | 45.01 | TRUE | 0 | 0 |
| 2026-01-16 | 80 | 0 | PUT | 0 | 0 | 43.8 | TRUE | 0 | 0 |
Latest CRNX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 5 | $17.17 |
| Jun 13, 2022 7:59 PM EST | 100 | $17.19 |
| Jun 13, 2022 7:59 PM EST | 1 | $17.17 |
| Jun 13, 2022 7:59 PM EST | 100 | $17.2 |
| Jun 13, 2022 7:59 PM EST | 100 | $17.2 |
Crinetics Pharmaceuticals, Inc (CRNX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm |
| 2018-07-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1658247/000000000018021079/0000000000-18-021079-index.htm |
| 2019-08-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1658247/000000000019012560/0000000000-19-012560-index.htm |
| 2018-09-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000031506618002299/0000315066-18-002299-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000031506619000968/0000315066-19-000968-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000031506620000861/0000315066-20-000861-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019963/0000899243-18-019963-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019964/0000899243-18-019964-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019965/0000899243-18-019965-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019967/0000899243-18-019967-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019968/0000899243-18-019968-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019972/0000899243-18-019972-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019974/0000899243-18-019974-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019975/0000899243-18-019975-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019978/0000899243-18-019978-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318019979/0000899243-18-019979-index.htm |
| 2018-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm |
| 2019-02-12 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924319003318/0000899243-19-003318-index.htm |
| 2019-02-12 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924319003326/0000899243-19-003326-index.htm |
| 2020-04-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm |
| 2018-07-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000094787118000610/0000947871-18-000610-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000101297518000919/0001012975-18-000919-index.htm |
| 2018-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm |
| 2018-08-27 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000101297518001046/0001012975-18-001046-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465918045567/0001104659-18-045567-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465918045579/0001104659-18-045579-index.htm |
| 2018-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465918046292/0001104659-18-046292-index.htm |
| 2018-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm |
| 2018-07-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000110465918048071/0001104659-18-048071-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465919006113/0001104659-19-006113-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000110465919008632/0001104659-19-008632-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465919010154/0001104659-19-010154-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm |
| 2020-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000110465920011470/0001104659-20-011470-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000110465920021136/0001104659-20-021136-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000114420419008307/0001144204-19-008307-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000117266120000650/0001172661-20-000650-index.htm |
| 2018-07-12 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1658247/000119312518216421/0001193125-18-216421-index.htm |
| 2018-07-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1658247/000119312518217820/0001193125-18-217820-index.htm |
| 2018-07-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1658247/000119312518217824/0001193125-18-217824-index.htm |
| 2018-07-17 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1658247/000119312518219860/0001193125-18-219860-index.htm |
| 2018-07-18 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1658247/000119312518220701/0001193125-18-220701-index.htm |
| 2018-07-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1658247/000119312518220704/0001193125-18-220704-index.htm |
| 2018-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000119312518222517/0001193125-18-222517-index.htm |
| 2018-07-30 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1658247/000119312518231543/0001193125-18-231543-index.htm |
| 2018-08-28 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1658247/000119312518259557/0001193125-18-259557-index.htm |
| 2018-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000119312518263610/0001193125-18-263610-index.htm |
| 2018-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000119312518289506/0001193125-18-289506-index.htm |
| 2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000119312518325476/0001193125-18-325476-index.htm |
| 2019-08-13 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1658247/000119312519220012/0001193125-19-220012-index.htm |
| 2019-08-19 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1658247/000119312519224488/0001193125-19-224488-index.htm |
| 2019-08-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1658247/000119312519224495/0001193125-19-224495-index.htm |
| 2019-08-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1658247/000119312519230761/0001193125-19-230761-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000119312520099551/0001193125-20-099551-index.htm |
| 2020-04-14 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1658247/000119312520107151/0001193125-20-107151-index.htm |
| 2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000119312520107156/0001193125-20-107156-index.htm |
| 2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000119312520108092/0001193125-20-108092-index.htm |
| 2020-04-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1658247/000119312520108096/0001193125-20-108096-index.htm |
| 2020-04-20 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1658247/000119312520111625/0001193125-20-111625-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119018982/0001209191-19-018982-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119018983/0001209191-19-018983-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119018984/0001209191-19-018984-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119038894/0001209191-19-038894-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119038896/0001209191-19-038896-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119038897/0001209191-19-038897-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119038902/0001209191-19-038902-index.htm |
| 2019-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119038905/0001209191-19-038905-index.htm |
| 2019-07-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119042285/0001209191-19-042285-index.htm |
| 2019-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119042286/0001209191-19-042286-index.htm |
| 2019-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm |
| 2020-02-11 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120008269/0001209191-20-008269-index.htm |
| 2020-02-11 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120008272/0001209191-20-008272-index.htm |
| 2020-02-11 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120008280/0001209191-20-008280-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120012974/0001209191-20-012974-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120012987/0001209191-20-012987-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120012997/0001209191-20-012997-index.htm |
| 2020-03-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120021372/0001209191-20-021372-index.htm |
| 2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120038153/0001209191-20-038153-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120038161/0001209191-20-038161-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120038166/0001209191-20-038166-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120038172/0001209191-20-038172-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm |
| 2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm |
| 2020-09-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120049508/0001209191-20-049508-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000120919120049518/0001209191-20-049518-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2020-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003601/0001213900-20-003601-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm |
| 2020-04-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm |
| 2020-06-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000121390020014709/0001213900-20-014709-index.htm |
| 2018-07-12 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1658247/000135445718000250/0001354457-18-000250-index.htm |
| 2018-08-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459018022504/0001564590-18-022504-index.htm |
| 2018-11-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459018029304/0001564590-18-029304-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459019007555/0001564590-19-007555-index.htm |
| 2019-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1658247/000156459019007561/0001564590-19-007561-index.htm |
| 2019-04-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459019011511/0001564590-19-011511-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1658247/000156459019013719/0001564590-19-013719-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1658247/000156459019013723/0001564590-19-013723-index.htm |
| 2019-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459019018827/0001564590-19-018827-index.htm |
| 2019-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459019018831/0001564590-19-018831-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459019023431/0001564590-19-023431-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459019025016/0001564590-19-025016-index.htm |
| 2019-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459019031797/0001564590-19-031797-index.htm |
| 2019-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459019031801/0001564590-19-031801-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459019042893/0001564590-19-042893-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459019042900/0001564590-19-042900-index.htm |
| 2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000156459020004205/0001564590-20-004205-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020009362/0001564590-20-009362-index.htm |
| 2020-03-09 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1658247/000156459020009365/0001564590-20-009365-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1658247/000156459020019202/0001564590-20-019202-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1658247/000156459020019210/0001564590-20-019210-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020023260/0001564590-20-023260-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459020023265/0001564590-20-023265-index.htm |
| 2020-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020030117/0001564590-20-030117-index.htm |
| 2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020038067/0001564590-20-038067-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459020038069/0001564590-20-038069-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020042431/0001564590-20-042431-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020044046/0001564590-20-044046-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020047499/0001564590-20-047499-index.htm |
| 2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1658247/000156459020051684/0001564590-20-051684-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1658247/000156459020051686/0001564590-20-051686-index.htm |
| 2018-07-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000161577418006600/0001615774-18-006600-index.htm |
| 2018-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm |
| 2018-07-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1658247/000161577418006903/0001615774-18-006903-index.htm |
| 2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm |
| 2018-07-17 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1658247/999999999518001811/9999999995-18-001811-index.htm |
| 2019-08-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1658247/999999999519002011/9999999995-19-002011-index.htm |
Crinetics Pharmaceuticals, Inc (CRNX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crinetics Pharmaceuticals, Inc (CRNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 450%Institutional Ownership: 9514%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-03-18 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 6,194.00 | 24.25 | 150,208.84 | 104,489.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm |
| 2019-08-05 | Richard Scott Struthers | President & CEO | Buy | 10,000.00 | 1.91 | 19,100.00 | 1,225,805.00 | https://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm |
| 2019-12-16 | Matthew K Fust | Director | Sell | 3,500.00 | 22.50 | 78,750.00 | 12,536.00 | https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm |
| 2019-01-22 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 10,486.00 | 21.88 | 229,381.25 | 129,483.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm |
| 2018-07-20 | 5AM Ventures IV, L.P. | 10% Share Holder | Buy | 4,600.00 | 17.00 | 78,200.00 | 139,969.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm |
| 2018-07-20 | Vivo Capital VIII, LLC | 10% Share Holder | Buy | 141,177.00 | 17.00 | 2,400,009.00 | 141,177.00 | https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm |
| 2019-12-16 | Matthew K Fust | Director | Buy | 3,500.00 | 1.91 | 6,685.00 | 16,036.00 | https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm |
| 2020-03-09 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 133.00 | 19.50 | 2,593.50 | 168,165.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm |
| 2020-02-10 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 5,904.00 | 21.40 | 126,345.60 | 168,298.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm |
| 2020-02-07 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 4,614.00 | 22.00 | 101,508.00 | 174,202.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm |
| 2020-02-04 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 10,519.00 | 22.80 | 239,833.20 | 178,816.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm |
| 2020-01-31 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 4,220.00 | 21.70 | 91,574.00 | 189,335.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2020-01-30 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 5,940.00 | 22.10 | 131,274.00 | 193,555.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2020-01-29 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 10,878.00 | 22.20 | 241,491.60 | 199,495.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2018-07-20 | Alan Seth Krasner | Chief Medical Officer | Buy | 2,000.00 | 17.00 | 34,000.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm |
| 2019-03-20 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 83,984.00 | 22.25 | 1,868,644.00 | 210,373.00 | https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm |
| 2020-04-17 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 74,333.00 | 15.40 | 1,144,728.20 | 2,162,587.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm |
| 2020-04-16 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 26,527.00 | 15.20 | 403,210.40 | 2,236,920.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm |
| 2020-04-15 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 189,625.00 | 15.50 | 2,939,187.50 | 2,263,447.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm |
| 2019-06-21 | 5AM Ventures IV, L.P. | Insider | Sell | 240,000.00 | 22.20 | 5,328,000.00 | 2,267,797.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm |
| 2018-07-20 | PERCEPTIVE ADVISORS LLC | Director | Buy | 400,000.00 | 17.00 | 6,800,000.00 | 2,280,305.00 | https://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm |
| 2020-04-07 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 5,373.00 | 14.20 | 76,296.60 | 2,453,072.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm |
| 2020-04-03 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 263,600.00 | 13.80 | 3,637,680.00 | 2,458,445.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm |
| 2019-03-18 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 148,645.00 | 24.25 | 3,604,745.30 | 2,507,797.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm |
| 2020-03-09 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 347.00 | 19.50 | 6,766.50 | 2,722,045.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm |
| 2020-02-10 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 1,451.00 | 21.40 | 31,051.40 | 2,722,392.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm |
| 2020-02-07 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 1,134.00 | 22.00 | 24,948.00 | 2,723,843.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm |
| 2020-02-04 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 2,584.00 | 22.80 | 58,915.20 | 2,724,977.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm |
| 2020-01-31 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 1,037.00 | 21.70 | 22,502.90 | 2,727,561.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2020-01-30 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 1,459.00 | 22.10 | 32,243.90 | 2,728,598.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2020-01-29 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 2,673.00 | 22.20 | 59,340.60 | 2,730,057.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2019-03-20 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 292,609.00 | 22.25 | 6,510,550.25 | 2,732,730.00 | https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm |
| 2018-07-20 | Vivo Capital VIII, LLC | 10% Share Holder | Buy | 153,180.00 | 20.73 | 3,175,421.40 | 294,357.00 | https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm |
| 2020-04-17 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 10,265.00 | 15.40 | 158,081.00 | 298,625.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm |
| 2018-07-20 | Vivo Capital VIII, LLC | 10% Share Holder | Buy | 51,686.00 | 17.00 | 878,662.00 | 3,025,339.00 | https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm |
| 2020-04-16 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 3,663.00 | 15.20 | 55,677.60 | 308,890.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm |
| 2019-01-22 | 5AM Ventures IV, L.P. | 10% Share Holder | Sell | 251,667.00 | 21.88 | 5,505,215.63 | 3,107,642.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm |
| 2020-04-15 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 26,185.00 | 15.50 | 405,867.50 | 312,553.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm |
| 2018-07-20 | 5AM Ventures IV, L.P. | 10% Share Holder | Buy | 110,400.00 | 17.00 | 1,876,800.00 | 3,359,309.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm |
| 2020-04-07 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 742.00 | 14.20 | 10,536.40 | 338,738.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm |
| 2020-04-03 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 36,400.00 | 13.80 | 502,320.00 | 339,480.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm |
| 2020-04-17 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 1,071,428.00 | 14.00 | 14,999,992.00 | 3,659,381.00 | https://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm |
| 2020-03-09 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 48.00 | 19.50 | 936.00 | 375,880.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm |
| 2020-02-10 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 200.00 | 21.40 | 4,280.00 | 375,928.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm |
| 2020-02-07 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 157.00 | 22.00 | 3,454.00 | 376,128.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm |
| 2020-02-04 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 357.00 | 22.80 | 8,139.60 | 376,285.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm |
| 2020-01-31 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 143.00 | 21.70 | 3,103.10 | 376,642.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2020-01-30 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 201.00 | 22.10 | 4,442.10 | 376,785.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2020-01-29 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 369.00 | 22.20 | 8,191.80 | 376,986.00 | https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm |
| 2019-03-20 | Vivo Capital VIII, LLC | 10% Share Holder | Sell | 40,407.00 | 22.25 | 899,055.75 | 377,355.00 | https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm |
| 2018-07-20 | Vivo Capital VIII, LLC | 10% Share Holder | Buy | 7,137.00 | 17.00 | 121,329.00 | 417,762.00 | https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm |
| 2020-07-16 | Richard Scott Struthers | President & CEO | Sell | 17,500.00 | 14.46 | 253,107.75 | 890,805.00 | https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm |
| 2020-07-15 | Richard Scott Struthers | President & CEO | Sell | 17,500.00 | 15.30 | 267,722.00 | 908,305.00 | https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm |
| 2019-06-21 | 5AM Ventures IV, L.P. | Insider | Sell | 10,000.00 | 22.20 | 222,000.00 | 94,489.00 | https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm |
| 2020-04-28 | WENDALL WIERENGA | Director | Buy | 25,329.00 | 0.73 | 18,490.17 | 99,846.00 | https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm |